Federal court blocks nationwide mail delivery of abortion medication mifepristone

A federal appeals court has temporarily blocked the mailing of mifepristone, a medication used in abortion procedures. The ruling affects access to abortion pills nationwide.

The decision was made by a three-judge panel on the US Court of Appeals for the District of Columbia Circuit. The court’s order restricts the distribution of mifepristone through mail services.

Mifepristone is a medication that can be used in combination with another drug, misoprostol, to induce abortion. It was previously approved by the FDA for use in medical settings, but the agency also allowed its distribution through pharmacies and online retailers.

The appeals court’s decision does not immediately affect existing prescriptions or shipments of mifepristone. However, it may impact future deliveries of the medication.

The ruling is part of a larger debate over access to abortion services in the United States. The FDA had previously approved the use of mifepristone for medical abortions, but some states have implemented restrictions on its distribution.

The court’s decision will be reviewed by the full appeals court and may eventually reach the US Supreme Court.

Source: Google News World